Autonomic dysfunction in Huntington’s disease: A 123I-MIBG study

[11] Tachibana N(2005)Cortical regions associated with autonomic cardiovascular regulation during lower body negative pressure in humans J Physiol 30 1307-699

[12] Hamano T(1999)Effects of stroke localization on cardiac autonomic balance and sudden death Stroke 59 691-303

[13] Odagiri H(2006)Insular involvement in brain infarction increases risk for cardiac arrhythmia and death Ann Neurol 20 296-35

[14] Baba T(1986)PET scan investigations of Huntington’s disease: cerebral metabolic correlates of neurological features and functional decline Ann Neurol 12 23-603

[15] Nishio Y(2013)Consistent neurodegeneration and its association with clinical progression in Huntington’s disease: A coordinate-based meta-analysis Neurodegener Dis 3 595-1074

[16] Iizuka O(2010)Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction Circ Cardiovasc Imaging 17 1068-undefined

[17] Matsuda M(2010)Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington’s disease Eur J Neurol undefined undefined-undefined

[18] Inoue K(undefined)undefined undefined undefined undefined-undefined

[19] Huikuri HV(undefined)undefined undefined undefined undefined-undefined

[20] Castellanos A(undefined)undefined undefined undefined undefined-undefined

[11] Tachibana N(2005)Cortical regions associated with autonomic cardiovascular regulation during lower body negative pressure in humans J Physiol 30 1307-699

[12] Hamano T(1999)Effects of stroke localization on cardiac autonomic balance and sudden death Stroke 59 691-303

[13] Odagiri H(2006)Insular involvement in brain infarction increases risk for cardiac arrhythmia and death Ann Neurol 20 296-35

[14] Baba T(1986)PET scan investigations of Huntington’s disease: cerebral metabolic correlates of neurological features and functional decline Ann Neurol 12 23-603

[15] Nishio Y(2013)Consistent neurodegeneration and its association with clinical progression in Huntington’s disease: A coordinate-based meta-analysis Neurodegener Dis 3 595-1074

[16] Iizuka O(2010)Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction Circ Cardiovasc Imaging 17 1068-undefined

[17] Matsuda M(2010)Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington’s disease Eur J Neurol undefined undefined-undefined

[18] Inoue K(undefined)undefined undefined undefined undefined-undefined

[19] Huikuri HV(undefined)undefined undefined undefined undefined-undefined

[20] Castellanos A(undefined)undefined undefined undefined undefined-undefined